Studies estimating65 and measuring66 the amount of insoluble tau protein in the human AD brain show that tau levels are significantly higher than control in symptomatic AD patients, but not in patients with prodromal or preclinical AD. This evidence concerns the gene MAPT and Alzheimer disease.